| 1 |
34948256 | Mucopolysaccharidosis Type VI, an Updated Overview of the Disease. | 2021 Dec 15 |
1 |
| 2 |
32664626 | A Possible Role for Arylsulfatase G in Dermatan Sulfate Metabolism. | 2020 Jul 12 |
2 |
| 3 |
29794138 | Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells. | 2018 Jul 13 |
1 |
| 4 |
30335002 | Family study of a novel mutation of mucopolysaccharidosis type VI with a severe phenotype and good response to enzymatic replacement therapy: Case report. | 2018 Oct |
1 |
| 5 |
30524696 | Mutational analysis of ARSB gene in mucopolysaccharidosis type VI: identification of three novel mutations in Iranian patients. | 2018 Sep |
1 |
| 6 |
27826022 | Functional characterization of arylsulfatase B mutations in Indian patients with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). | 2017 Jan 30 |
3 |
| 7 |
27926479 | Decline in arylsulfatase B leads to increased invasiveness of melanoma cells. | 2017 Jan 17 |
1 |
| 8 |
29081414 | Arylsulfatase B is reduced in prostate cancer recurrences. | 2017 Dec 12 |
2 |
| 9 |
29245974 | Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3). | 2017 Nov 21 |
1 |
| 10 |
26909334 | Molecular findings of Colombian patients with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). | 2016 Feb |
1 |
| 11 |
27078017 | Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF. | 2016 |
2 |
| 12 |
27605497 | Restriction of Aerobic Metabolism by Acquired or Innate Arylsulfatase B Deficiency: A New Approach to the Warburg Effect. | 2016 Sep 8 |
1 |
| 13 |
25797215 | Deletion of exon 4 in the N-acetylgalactosamine-4-sulfatase gene in a Taiwanese patient with mucopolysaccharidosis type VI. | 2015 Apr |
4 |
| 14 |
25892708 | Identifying the need for a multidisciplinary approach for early recognition of mucopolysaccharidosis VI (MPS VI). | 2015 May |
1 |
| 15 |
24221504 | Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature. | 2014 May |
4 |
| 16 |
24240681 | Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects. | 2014 Nov 20 |
3 |
| 17 |
24243352 | Molecular Analysis of Turkish Maroteaux-Lamy Patients and Identification of One Novel Mutation in the Arylsulfatase B (ARSB) Gene. | 2014 |
2 |
| 18 |
25190157 | [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI]. | 2014 Jun |
2 |
| 19 |
22550062 | Reduced Arylsulfatase B activity in leukocytes from cystic fibrosis patients. | 2013 Mar |
3 |
| 20 |
22079206 | Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B. | 2012 Sep |
5 |
| 21 |
22428001 | Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia. | 2012 |
1 |
| 22 |
23023219 | Identification of a novel arylsulfatase B gene mutation in three unrelated Iranian mucopolysaccharidosis type-VI patients with different phenotype severity. | 2012 |
2 |
| 23 |
20980181 | Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. | 2011 Feb |
2 |
| 24 |
21378286 | Extra-lysosomal localization of arylsulfatase B in human colonic epithelium. | 2011 Mar |
6 |
| 25 |
20152898 | Arylsulfatase B regulates interaction of chondroitin-4-sulfate and kininogen in renal epithelial cells. | 2010 May |
4 |
| 26 |
20385007 | Mucopolysaccharidosis VI. | 2010 Apr 12 |
1 |
| 27 |
18418554 | Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapy. | 2009 Aug |
1 |
| 28 |
19682969 | Development of a functional bioassay for arylsulfatase B using the natural substrates of the enzyme. | 2009 Dec 15 |
6 |
| 29 |
17672828 | Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease. | 2008 Mar |
3 |
| 30 |
18406185 | Maroteaux-Lamy syndrome: functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene. | 2008 Jul |
2 |
| 31 |
18486607 | Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients. | 2008 Aug |
2 |
| 32 |
17324393 | Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR. | 2007 May 1 |
3 |
| 33 |
16435196 | Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients. | 2005 |
2 |
| 34 |
12796199 | Does deficiency of arylsulfatase B have a role in cystic fibrosis? | 2003 Jun |
2 |
| 35 |
15000815 | Identification of a novel mutation in the ARSB gene that is frequent among Brazilian MPSVI patients. | 2003 Winter |
2 |
| 36 |
11322427 | Findings in the anterior segment on ultrasound biomicroscopy in Maroteaux-Lamy syndrome. | 2001 Apr |
1 |
| 37 |
11668612 | Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase. | 2001 Oct |
2 |
| 38 |
8651289 | Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. | 1996 Jun |
1 |
| 39 |
8755662 | Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy. | 1996 Jul 15 |
3 |
| 40 |
1427856 | Feline arylsulfatase B (ARSB): isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1. | 1992 Oct |
2 |